Cerity Partners
OM icon

Cerity Partners’s Outset Medical OM Stock Holding History

Cerity Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.1K Buy
19,009
+6,272
+49% +$27.4K ﹤0.01% 3242
2026
Q1 		$48.9K Buy
+12,737
New +$52.2K ﹤0.01% 3111
2023
Q1 		– Sell
-723
Closed -$280K – 1886
2022
Q4 		$280K Sell
723
-7
-1% -$1.97K ﹤0.01% 1173
2022
Q3 		$174K Buy
+730
New +$195K ﹤0.01% 1073

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Cerity Partners's OM Position: Q2 2026 in Review

Cerity Partners increased its Outset Medical (OM) stake by 49% in Q2 2026, buying an estimated $27.4K and bringing the position to 19,009 shares worth $82.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Cerity Partners first reported a position in OM in Q3 2022 and has held it in 4 quarters since. The position peaked at $280K in Q4 2022. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Cerity Partners held 19,009 shares of Outset Medical worth $82.1K as of Q2 2026.
  • Cerity Partners bought 6,272 Outset Medical shares in Q2 2026, an estimated $27.4K.
  • Outset Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3242 holding.
  • Cerity Partners first reported a position in Outset Medical in Q3 2022 and has held it in 4 quarters since.
  • Cerity Partners's Outset Medical position peaked at $280K in Q4 2022.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.